|
skos:definition |
MSH: Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI.,CSP: phospholipids secreted by the great alveolar cells into alveoli and respiratory air passages which contributes to the elastic property of pulmonary tissue.,FMA: Secretion produced by Type 2 pulmonary alveolar cell.,NCI: Pulmonary surfactant lines the lung epithelium and lowers surface tension to prevent collapse at end-expiration. Deficiency of pulmonary surfactant results in respiratory distress syndrome (RDS) in premature infants. Lung surfactant is synthesized in alveolar type II cells, stored in lamellar bodies and secreted via exocytosis. (NCI),UWDA: Secretion produced by Type 2 pulmonary alveolar cell.,NCI: Pulmonary surfactant lines the lung epithelium and lowers surface tension to prevent collapse at end-expiration. Deficiency of pulmonary surfactant results in respiratory distress syndrome (RDS) in premature infants. Lung surfactant is synthesized in alveolar type II cells, stored in lamell
|
